Watchdog group warns of heart valve risk related to new diet pill

Reuters reports now that FDA has approved Arena Pharmaceuticals’ diet pill lorcaserin, the watchdog group Public Citizen has asked the US Food and Drug Administration to reject the experimental drug, citing concerns that it could pose a risk to heart valves.

The group noted that doctors at an FDA advisory meeting said evidence from clinical trials showed an increased heart valve disease risk in patients who used lorcaserin. The panel still voted to recommend the drug for approval by a vote of 18 to 4.

U-T San Diego reports the FDA “could delay its decision and require Arena to file more information about Lorcaserin, which become the first new weight loss drug of its kind approved in the US in more than a decade.”

This entry was posted in General Health. Bookmark the permalink.